FCE-27993

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameFCE-27993
Drug Alias NameFCE-27993
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAromatase inhibitors
TargetsAromatase
Therapy Area/IndicationsProstatic NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmacia & Upjohn Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmacia & Upjohn Spa
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A